⛽Southern Natural Gas Pipeline Regulatory Notice and Participation Details
The Federal Energy Regulatory Commission (FERC) has issued a notice regarding Southern Natural Gas Company's request to reduce the maximum allowable operating pressure of a pipeline in Georgia. The document invites public participation through protests, interventions, and comments, highlighting deadlines for involvement and supporting resources for stakeholders.
Learn More⚡Preliminary Permit Application for Maynard Hydroelectric Project
The Federal Energy Regulatory Commission has accepted a preliminary permit application from Maynard Hydroelectric, LLC, to explore the feasibility of a hydropower project at the Colonel Charles D. Maynard Lock and Dam on the Arkansas River. The application invites public comments and proposes a project with significant energy generation potential.
Learn More⛴️Request Notice for Foreign-Built Passenger Vessel Use in U.S. Trade
The Secretary of Transportation, as represented by MARAD, is authorized to make determinations regarding the coastwise use of foreign built; certain U.S. built; and U.S. and foreign rebuilt vessels that solely carry no more than twelve passengers for hire. MARAD has received such a determination request and is publishing this notice to solicit comments to assist with determining whether the proposed use of the vessel set forth in the request would have an adverse effect on U.S. vessel builders or U.S. coastwise trade businesses that use U.S.- built vessels in those businesses. Information about the requestor's vessel, including a description of the proposed service, is in the SUPPLEMENTARY INFORMATION section below.
Learn More📄Marine Corps Officer Candidate Program Information Collection Notice
The DoD has submitted to the Office of Management and Budget (OMB) for clearance the following proposal for collection of information under the provisions of the Paperwork Reduction Act.
Learn More💉Overview of the National Vaccine Injury Compensation Program
HRSA is publishing this notice of petitions received under the National Vaccine Injury Compensation Program (the Program), as required by the Public Health Service (PHS) Act, as amended. While the Secretary of HHS is named as the respondent in all proceedings brought by the filing of petitions for compensation under the Program, the United States Court of Federal Claims is charged by statute with responsibility for considering and acting upon the petitions.
Learn More⚠️NRC Public Meeting on Wolf Creek Nuclear Site Release Request
The U.S. Nuclear Regulatory Commission (NRC) is considering a request from Wolf Creek Nuclear Operating Corporation (WCNOC, the licensee) to approve the release of 4.46 acres of land under the control of the NRC power reactor license for the WCNOC, Operating License No. NPF-42, to the Stringtown Cemetery Board. The NRC is soliciting public comments on the requested action and invites stakeholders and interested persons to participate.
Learn More🤖RFI on AI Regulations and Business Innovation Impacts
The Office of Science and Technology Policy (OSTP) requests input from all interested parties in identifying existing Federal statutes, regulations, agency rules, guidance, forms, and administrative processes that unnecessarily hinder the development, deployment, and adoption of artificial intelligence (AI) technologies within the United States. Through this Request for Information (RFI), OSTP is seeking input from the public, including private sector organizations, industry groups, academia, state, local, and tribal governments, and any other interested parties, on priorities for such regulatory reform or other agency action necessary to promote AI innovation and adoption.
Learn More🧬FDA Guidance on Postapproval Safety and Efficacy for CGT Products
The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a draft document entitled "Postapproval Methods to Capture Safety and Efficacy Data for Cell and Gene Therapy Products; Draft Guidance for Industry." The draft guidance document discusses methods and approaches for capturing postapproval safety and efficacy data for cell and gene therapy (CGT) products. Given the potential for long-lasting effects of CGT products, and the generally limited number of participants treated in clinical trials, the collection of postapproval study data for CGT products is important for gathering data on product safety and effectiveness over time.
Learn More📄SEC Review of Rule 12d1-3 Information Collection Request
The SEC announces the submission for OMB review for extension of Rule 12d1-3, which mandates certification for securities listing and registration. The notice details the estimated burden on respondents and highlights the public commentary opportunity for the information collection request.
Learn More🚬FDA Notice on Reporting Harmful Constituents in Tobacco Products
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Learn More